|1.||Hirvonen, Ari: 5 articles (01/2006 - 03/2002)|
|2.||Zhang, Yi: 4 articles (01/2015 - 01/2013)|
|3.||Saadat, Mostafa: 4 articles (11/2014 - 07/2004)|
|4.||London, Stephanie J: 4 articles (01/2009 - 08/2002)|
|5.||Kang, Daehee: 4 articles (11/2006 - 03/2002)|
|6.||Tsai, Fuu-Jen: 4 articles (11/2005 - 07/2004)|
|7.||Garte, Seymour: 4 articles (09/2005 - 05/2003)|
|8.||Tamer, Lülüfer: 4 articles (07/2005 - 09/2004)|
|9.||Ateş, Nurcan Aras: 4 articles (07/2005 - 09/2004)|
|10.||Kalina, Ivan: 4 articles (02/2004 - 07/2002)|
|1.||Prostatic Neoplasms (Prostate Cancer)
01/01/2013 - "Many studies have investigated associations between the glutathione S-transferase M1 (GSTM1) null polymorphism and risk of prostate cancer, but the impact of GSTM1 in people who live in Asian countries is still unclear owing to inconsistencies across results. "
01/01/2013 - "Genetic polymorphisms of glutathione S-transferase M1 and prostate cancer risk in Asians: a meta-analysis of 18 studies."
10/01/2010 - "Polymorphisms of glutathione-S-transferase M1 and T1 and prostate cancer risk in a Tunisian population."
01/01/2009 - "Polymorphisms of glutathione-S-transferase M1, T1, P1 and the risk of prostate cancer: a case-control study."
10/01/2006 - "Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis."
|2.||Parkinson Disease (Parkinson's Disease)
01/30/2003 - "Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease."
04/01/2004 - "The present study was conducted to examine the interaction between cytochrome p450 2D6: CYP2D6 (phase I) poor metabolizer (PM) and glutathione S-transferase M1: GSTM1 (phase II) null genotypes, among 103 unrelated French Parkinson's disease (PD) patients. "
03/15/2014 - "The Glutathione S-transferase M1 (GSTM1) and Glutathione S-transferase T1 (GSTT1) genes have been studied extensively as potential candidate genes for the risk of Parkinson's disease (PD). "
03/15/2014 - "Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson's disease: a meta-analysis."
02/01/2004 - "A number of other candidate gene polymorphisms including cytochrome P450 2D6, N-acetyltransferase 2, monoamine oxidase-B and glutathione-s-transferase M1 are implicated in sporadic and familial cases and may also play a minor role in the aetiology of Parkinson's disease."
|3.||Open-Angle Glaucoma (Glaucoma, Open Angle)
04/01/2005 - "May glutathione S-transferase M1 positive genotype afford protection against primary open-angle glaucoma?"
04/01/2007 - "Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population."
11/01/2000 - "Polymorphic glutathione S-transferase M1 is a risk factor of primary open-angle glaucoma among Estonians."
03/01/2014 - "Glutathione S-transferase M1 (GSTM1) polymorphism has been proven to be associated with risks of several cancers. "
01/01/2013 - "Association of the glutathione s-transferase m1, t1 polymorphisms with cancer: evidence from a meta-analysis."
12/01/2011 - "The glutathione S-transferase M1 null polymorphism was associated with increased risk of low-grade intra-epithelial lesions (OR 1.37, 95% CI 1.05-1.77), but no increased risk of high-grade intra-epithelial lesions (OR 1.29, 95% CI 0.87-1.8) or invasive cervical cancer (OR 1.20, 95% CI 0.99-1.46). "
06/01/2011 - "Glutathione S-transferase M1 (GSTM1) might be involved in inactivation of procarcinogens that contribute to the genesis and progression of cancers. "
01/01/2011 - "Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: a meta-analysis."
|5.||Hepatocellular Carcinoma (Hepatoma)
01/01/2006 - "Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: a study in the Spanish population."
06/01/1999 - "To Study whether the mutation of deletion for glutathione S-transferase M1 (GSTM1) gene occurred during the development of hepatocellular carcinoma (HCC). "
08/01/2014 - "Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) have been involved in the risk of hepatocellular carcinoma (HCC). "
08/01/2014 - "Interactive effect of glutathione S-transferase M1 and T1 polymorphisms on hepatocellular carcinoma."
01/01/2014 - "Glutathione S-transferase M1 (GSTM1) have been reported to be associated with hepatocellular carcinoma. "
|1.||Cytochrome P-450 CYP1A1 (CYP1A1)
|3.||DNA (Deoxyribonucleic Acid)
|6.||Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)
|9.||Gonadal Steroid Hormones (Sex Hormones)
|10.||Androgen Receptors (Androgen Receptor)
|2.||Drug Therapy (Chemotherapy)